Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Recurrence Rate
100%
Distant Metastasis
100%
Hormone Receptor-positive
100%
Negative Breast Cancer
100%
Tumor
66%
Primary Tumor
50%
Estrogen Receptor
33%
High-level Expression
33%
Estrogen Receptor-positive
33%
Median Time
33%
Hazard Ratio
16%
Breast Cancer
16%
Clinical Outcomes
16%
Progesterone Receptor
16%
Signaling Molecules
16%
Breast Cancer Patients
16%
Human Epidermal Growth Factor Receptor 2 (HER2)
16%
Am(III)
16%
Tumor Tissue
16%
Chest Wall
16%
Survival Factor
16%
Impact Time
16%
Tumor Size
16%
Estrogen Receptor-negative
16%
Risk Prediction
16%
Correlation-regression Analysis
16%
Factor Correlation
16%
Tumor Grade
16%
Tumor Aggressiveness
16%
Metastases to Lung
16%
Early Recurrence
16%
Primary Breast Cancer
16%
Size Grading
16%
Recurrence Site
16%
Tumor Microarray
16%
14-3-3 Gene
16%
Nodal Status
16%
Recurrence Property
16%
Clinical Pathological Characteristics
16%
Metastasis Sites
16%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Recurrent Disease
100%
Hormone Receptor
100%
Distant Metastasis
100%
Neoplasm
70%
Estrogen Receptor
50%
Primary Tumor
40%
Protein P53
10%
Progesterone Receptor
10%
Epidermal Growth Factor Receptor
10%
Survival Factor
10%
Neuroscience
Estrogen Receptor
100%
Hormone Receptor
100%
P53
20%
Epidermal Growth Factor Receptor
20%
Progesterone Receptor
20%